Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients-Reference-Cited by-同舟云学术

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients

Published:2017-12 Issue:1 Volume:18 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Vázquez-Alvarez Alan O.,Brennan-Bourdon Lorena Michele,Rincón-Sánchez Ana Rosa,Islas-Carbajal María Cristina,Huerta-Olvera Selene G.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1186/s40360-017-0186-x.pdf

Reference40 articles.

1. COFEPRIS. Norma Oficial Mexicana NOM-220-SSA1–2012, Instalación y operación de la farmacovigilancia. 2013. http://www.dof.gob.mx/nota_detalle.php?codigo=5490830&fecha=19/07/2017 .

2. Rodríguez BJ, Leticia GVJL, Carmen GB, et al. Farmacovigilancia I. El inicio. Rev Med IMSS. 2004;42:327–9.

3. WHO. Internacional drugmonitoring: the role of national centres. Rep a WHO Meet. 1972:1–25.

4. Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011;71(5):684–700. doi: 10.1111/j.1365-2125.2010.03774.x .

5. Hr M. Medication use in an imperfect world: Drug misadventuring as an issue of public policy, part 2. Am J Hosp Pharm. 1989;46:1141–52.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review;Drug Safety;2024-08-19

2. Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study;Children;2023-11-01

3. Polypharmacy as risk factor of interdrug interactions and possible cause of pharmacotherapy complications in multidisciplinary pediatric hospital;Medical alphabet;2023-01-11

4. Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports;Pediatric Drugs;2022-11-12

5. Pharmacovigilance study of amphotericin B for mucormycosis in post-COVID and non-COVID patients at a tertiary care hospital in Eastern India;Indian Journal of Pharmacology;2022-11